Invitae to buy Y Combinator company Clear Genetics
The acquisition of Clear Genetics will help Invitae to enhance its ability to scale and deliver genetic information…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Nov 19
The acquisition of Clear Genetics will help Invitae to enhance its ability to scale and deliver genetic information…
11 Nov 19
The Aveta System is a new hysteroscopy platform that combines HD video, fluid management and tissue resection into…
11 Nov 19
The new in vitro diagnostic (IVD) kit will be used in Lexent Bio’s next-generation sequencing (NGS)-based cancer diagnostics
08 Nov 19
The CE mark allows Biocept to commercialise the approved products across the European Union and other CE Mark…
08 Nov 19
Physicians can use the new cheek swab to screen patients with COPD for alpha-1 antitrypsin deficiency (Alpha-1)
08 Nov 19
Allen Technologies, the pioneer of interactive patient engagement solutions for 40 years, transforms the way hospitals engage, educate…
07 Nov 19
Vela Diagnostics has developed Sentosa SQ HIV-1 Genotyping Assay for detecting HIV-1 drug resistance mutations (DRMs)
07 Nov 19
MEDx and Lucence announced a strategic partnership in China to co-develop cancer-care tests
05 Nov 19
The developed kits will be used mainly for the detection of pathogens, particularly in the field of infectious…
04 Nov 19
Hardy Diagnostics, providing the latest designs from Orum International, of Milan, Italy.